(SYM) Symbotic - Overview
Stock: Automation, Robotics, Warehouse
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 97.9% |
| Relative Tail Risk | -10.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.30 |
| Alpha | 62.27 |
| Character TTM | |
|---|---|
| Beta | 2.325 |
| Beta Downside | 1.973 |
| Drawdowns 3y | |
|---|---|
| Max DD | 72.46% |
| CAGR/Max DD | 0.71 |
Description: SYM Symbotic February 05, 2026
Symbotic Inc. (NASDAQ: SYM) is a U.S.-based automation-technology firm that builds robotic systems to move pallets, cases and individual items inside modern warehouses, targeting efficiency gains at the front end of the supply chain. The company is headquartered in Wilmington, Massachusetts, and trades as a common stock within the Industrial Machinery & Supplies & Components sub-industry.
According to Symbotic’s most recent Form 10-K (FY 2025), the firm generated $1.12 billion in revenue, a 28 % year-over-year increase driven primarily by expanded contracts with large retailers-most notably a multi-year automation rollout with Walmart that now covers over 250 of its distribution centers. As of 30 January 2026, market-cap stood near $3.4 billion and the company reported a trailing-12-month (TTM) gross margin of 23.5 %. Key sector drivers that underpin Symbotic’s growth outlook include (1) sustained double-digit e-commerce sales growth (global e-commerce CAGR ≈ 12 % YoY in 2024-2025), (2) persistent labor-shortage pressures prompting retailers to invest in warehouse robotics, and (3) rising total cost-of-ownership advantages of modular automation platforms versus legacy conveyor systems. These macro trends suggest a favorable tailwind, but the company’s valuation remains sensitive to execution risk on large-scale deployments and potential supply-chain constraints for critical components.
For a deeper, data-driven assessment of SYM’s upside potential, you may want to explore ValueRay’s quantitative model.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 6.93m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.26 > 0.02 and ΔFCF/TA 18.56 > 1.0 |
| NWC/Revenue: 28.22% < 20% (prev 13.66%; Δ 14.56% < -1%) |
| CFO/TA 0.29 > 3% & CFO 853.5m > Net Income 6.93m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (127.9m) vs 12m ago 20.52% < -2% |
| Gross Margin: 19.51% > 18% (prev 0.15%; Δ 1936 % > 0.5%) |
| Asset Turnover: 101.5% > 50% (prev 111.6%; Δ -10.12% > 0%) |
| Interest Coverage Ratio: -3.58 > 6 (EBITDA TTM -32.2m / Interest Expense TTM -21.1m) |
Altman Z'' -0.20
| A: 0.23 (Total Current Assets 2.46b - Total Current Liabilities 1.78b) / Total Assets 2.99b |
| B: -0.45 (Retained Earnings -1.34b / Total Assets 2.99b) |
| C: -0.03 (EBIT TTM -75.6m / Avg Total Assets 2.35b) |
| D: 0.00 (Book Value of Equity 14.0k / Total Liabilities 2.03b) |
| Altman-Z'' Score: -0.20 = B |
Beneish M -3.15
| DSRI: 0.80 (Receivables 357.2m/357.7m, Revenue 2.39b/1.91b) |
| GMI: 0.79 (GM 19.51% / 15.41%) |
| AQI: 1.58 (AQ_t 0.14 / AQ_t-1 0.09) |
| SGI: 1.25 (Revenue 2.39b / 1.91b) |
| TATA: -0.28 (NI 6.93m - CFO 853.5m) / TA 2.99b) |
| Beneish M-Score: -3.15 (Cap -4..+1) = AA |
What is the price of SYM shares?
Over the past week, the price has changed by +9.88%, over one month by -15.20%, over three months by -14.88% and over the past year by +129.86%.
Is SYM a buy, sell or hold?
- StrongBuy: 8
- Buy: 2
- Hold: 8
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the SYM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 63.3 | 5.9% |
| Analysts Target Price | 63.3 | 5.9% |
| ValueRay Target Price | 84.7 | 41.7% |
SYM Fundamental Data Overview February 07, 2026
P/S = 14.4154
P/B = 27.4541
P/EG = 21.0966
Revenue TTM = 2.39b USD
EBIT TTM = -75.6m USD
EBITDA TTM = -32.2m USD
Long Term Debt = unknown (none)
Short Term Debt = 7.72m USD (from shortTermDebt, last fiscal year)
Debt = 31.7m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -1.82b USD (from netDebt column, last quarter)
Enterprise Value = 30.60b USD (32.39b + Debt 31.7m - CCE 1.82b)
Interest Coverage Ratio = -3.58 (Ebit TTM -75.6m / Interest Expense TTM -21.1m)
EV/FCF = 39.25x (Enterprise Value 30.60b / FCF TTM 779.7m)
FCF Yield = 2.55% (FCF TTM 779.7m / Enterprise Value 30.60b)
FCF Margin = 32.62% (FCF TTM 779.7m / Revenue TTM 2.39b)
Net Margin = 0.29% (Net Income TTM 6.93m / Revenue TTM 2.39b)
Gross Margin = 19.51% ((Revenue TTM 2.39b - Cost of Revenue TTM 1.92b) / Revenue TTM)
Gross Margin QoQ = 21.18% (prev 20.55%)
Tobins Q-Ratio = 10.22 (Enterprise Value 30.60b / Total Assets 2.99b)
Interest Expense / Debt = 360.5% (Interest Expense 114.2m / Debt 31.7m)
Taxrate = 21.0% (US default 21%)
NOPAT = -59.8m (EBIT -75.6m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.38 (Total Current Assets 2.46b / Total Current Liabilities 1.78b)
Debt / Equity = 0.03 (Debt 31.7m / totalStockholderEquity, last quarter 960.2m)
Debt / EBITDA = 56.43 (negative EBITDA) (Net Debt -1.82b / EBITDA -32.2m)
Debt / FCF = -2.33 (Net Debt -1.82b / FCF TTM 779.7m)
Total Stockholder Equity = 399.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.29% (Net Income 6.93m / Total Assets 2.99b)
RoE = 1.73% (Net Income TTM 6.93m / Total Stockholder Equity 399.4m)
RoCE = -6.25% (EBIT -75.6m / Capital Employed (Total Assets 2.99b - Current Liab 1.78b))
RoIC = -28.12% (negative operating profit) (NOPAT -59.8m / Invested Capital 212.5m)
WACC = 14.47% (E(32.39b)/V(32.42b) * Re(14.48%) + (debt cost/tax rate unavailable))
Discount Rate = 14.48% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 23.88%
[DCF Debug] Terminal Value 47.18% ; FCFF base≈519.2m ; Y1≈340.8m ; Y5≈155.5m
Fair Price DCF = 26.33 (EV 1.49b - Net Debt -1.82b = Equity 3.31b / Shares 125.8m; r=14.47% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 75.64 | EPS CAGR: 100.9% | SUE: 1.67 | # QB: 2
Revenue Correlation: 91.66 | Revenue CAGR: 65.02% | SUE: 0.29 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.11 | Chg30d=+0.016 | Revisions Net=+1 | Analysts=6
EPS current Year (2026-09-30): EPS=0.49 | Chg30d=+0.034 | Revisions Net=+1 | Growth EPS=-75.4% | Growth Revenue=+22.9%
EPS next Year (2027-09-30): EPS=0.75 | Chg30d=-0.019 | Revisions Net=+1 | Growth EPS=+54.4% | Growth Revenue=+28.7%